2010: Balancing of benefits and harms in health system decision-making / Data transparency as a precondition to the informed balancing of benefits and harms

How evidence-based can the balancing of benefits and harms be? (German)

Measurement of quality of life as a method for balancing benefits and harms? (German)

Differences between the balancing of risks and benefits (acc. to German Drug Law) and benefits and harms (acc. to Social Code Book V) (German)

Benefits and harms - two sides of the same coin? (German)

Balancing of benefits and harms in palliative medicine (German)

Balancing of benefits and harms of population-based measures using the example of cancer screening (German)

Legal regulations on data transparency - Comparison between the United States and Europe (German)

Data transparency in the field of medical devices (proposals by the medical device industry) (German)

Publication bias in studies beyond RCTs (German)

Implications of publication bias for the development and assessment of clinical practice guidelines (German)

Data transparency - an ethical imperative (German)

Programme IQWiG Autumn Symposium 2010

Short biographies of the speakers (German)